SEC Filing Details

Our enduring purpose: To fundamentally improve the lives of patients with serious diseases in ways never before possible

SEC Filing Details

Document Details

Form
Filing Date
Feb 28, 2019
Document Date
Feb 25, 2019
Form Description
Amendment to a previously filed 4
Filing Group
3,4,5
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS INC
Filer
WILLIAMS LEWIS T